Furthermore, we investigated whether AQP1 attenuates inflammatory responses via the p38 MAPK and NF-κB/IκBα signalling pathways in RAW264.7 macrophages to determine whether AQP1 is a potential therapeutic target for AKI. Here, NFKB1 is linked to acute kidney injury.